0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cefepime Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-26S7703
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Cefepime Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cefepime Market Research Report 2025

Code: QYRE-Auto-26S7703
Report
July 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cefepime Market

The global market for Cefepime was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cefepime is a fourth-generation cephalosporin.Its antibacterial spectrum has been further expanded, and it has strong antibacterial activity against a variety of gram-positive and negative bacteria, including enterobacteria, pseudomonas aeruginosa and other non-fermenter bacilli, haemophilus, staphylococcus, etc.Used for various infections caused by sensitive bacteria, mainly for respiratory tract infections caused by vicarious infections such as s. aureus, e. coli and pseudomonas aeruginosa.
North American market for Cefepime is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cefepime is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Cefepime include Baxter, Apotex, B. Braun Medical, Pfizer, Perrigo, Fresenius Kabi, Sandoz (Novartis), Piramal Critical Care, Meitheal Pharmaceuticals, BMS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cefepime, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cefepime.
The Cefepime market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cefepime market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cefepime manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cefepime Market Report

Report Metric Details
Report Name Cefepime Market
Segment by Type
  • Intramuscular Injection
  • Intravenous Drug Delivery
Segment by Application
  • Lower Respiratory Tract Infection
  • Urinary Tract Infection
  • Skin And Soft Tissue Infections
  • Abdominal Cavity Infection
  • Gynecologic Infection
  • Sepsis
  • Neutrophilic Fever
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter, Apotex, B. Braun Medical, Pfizer, Perrigo, Fresenius Kabi, Sandoz (Novartis), Piramal Critical Care, Meitheal Pharmaceuticals, BMS, Qilu Pharmaceutical, Sinopharm, Shanghai Xinfeng Pharmaceutical, Hebei Huamin Pharmaceutical, Nanjing Haichen Pharmaceutical, Shandong Luoxin Pharmaceutical Group, Guangzhou Baiyunshan Tianxin Pharmaceutical, Yuekang Pharmaceutical Group, Chengdu Beite Pharmaceutical, Jiangsu Hengrui Pharmaceutical, Hainan Star Pharmaceutical, Hainan Hailing Pharmaceutical, Shenzhen Xinlitai Pharmaceutical, Shenzhen Lijian Pharmaceutical, Suzhou Dongrui Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cefepime manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cefepime in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Cefepime Market report?

Ans: The main players in the Cefepime Market are Baxter, Apotex, B. Braun Medical, Pfizer, Perrigo, Fresenius Kabi, Sandoz (Novartis), Piramal Critical Care, Meitheal Pharmaceuticals, BMS, Qilu Pharmaceutical, Sinopharm, Shanghai Xinfeng Pharmaceutical, Hebei Huamin Pharmaceutical, Nanjing Haichen Pharmaceutical, Shandong Luoxin Pharmaceutical Group, Guangzhou Baiyunshan Tianxin Pharmaceutical, Yuekang Pharmaceutical Group, Chengdu Beite Pharmaceutical, Jiangsu Hengrui Pharmaceutical, Hainan Star Pharmaceutical, Hainan Hailing Pharmaceutical, Shenzhen Xinlitai Pharmaceutical, Shenzhen Lijian Pharmaceutical, Suzhou Dongrui Pharmaceutical

What are the Application segmentation covered in the Cefepime Market report?

Ans: The Applications covered in the Cefepime Market report are Lower Respiratory Tract Infection, Urinary Tract Infection, Skin And Soft Tissue Infections, Abdominal Cavity Infection, Gynecologic Infection, Sepsis, Neutrophilic Fever

What are the Type segmentation covered in the Cefepime Market report?

Ans: The Types covered in the Cefepime Market report are Intramuscular Injection, Intravenous Drug Delivery

1 Cefepime Market Overview
1.1 Product Definition
1.2 Cefepime by Type
1.2.1 Global Cefepime Market Value Comparison by Type (2024 VS 2031)
1.2.2 Intramuscular Injection
1.2.3 Intravenous Drug Delivery
1.3 Cefepime by Application
1.3.1 Global Cefepime Market Value by Application (2024 VS 2031)
1.3.2 Lower Respiratory Tract Infection
1.3.3 Urinary Tract Infection
1.3.4 Skin And Soft Tissue Infections
1.3.5 Abdominal Cavity Infection
1.3.6 Gynecologic Infection
1.3.7 Sepsis
1.3.8 Neutrophilic Fever
1.4 Global Cefepime Market Size Estimates and Forecasts
1.4.1 Global Cefepime Revenue 2020-2031
1.4.2 Global Cefepime Sales 2020-2031
1.4.3 Global Cefepime Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cefepime Market Competition by Manufacturers
2.1 Global Cefepime Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cefepime Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cefepime Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cefepime, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cefepime, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cefepime, Product Type & Application
2.7 Global Key Manufacturers of Cefepime, Date of Enter into This Industry
2.8 Global Cefepime Market Competitive Situation and Trends
2.8.1 Global Cefepime Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cefepime Players Market Share by Revenue
2.8.3 Global Cefepime Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cefepime Market Scenario by Region
3.1 Global Cefepime Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cefepime Sales by Region: 2020-2031
3.2.1 Global Cefepime Sales by Region: 2020-2025
3.2.2 Global Cefepime Sales by Region: 2026-2031
3.3 Global Cefepime Revenue by Region: 2020-2031
3.3.1 Global Cefepime Revenue by Region: 2020-2025
3.3.2 Global Cefepime Revenue by Region: 2026-2031
3.4 North America Cefepime Market Facts & Figures by Country
3.4.1 North America Cefepime Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cefepime Sales by Country (2020-2031)
3.4.3 North America Cefepime Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cefepime Market Facts & Figures by Country
3.5.1 Europe Cefepime Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cefepime Sales by Country (2020-2031)
3.5.3 Europe Cefepime Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cefepime Market Facts & Figures by Region
3.6.1 Asia Pacific Cefepime Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cefepime Sales by Region (2020-2031)
3.6.3 Asia Pacific Cefepime Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cefepime Market Facts & Figures by Country
3.7.1 Latin America Cefepime Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cefepime Sales by Country (2020-2031)
3.7.3 Latin America Cefepime Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cefepime Market Facts & Figures by Country
3.8.1 Middle East and Africa Cefepime Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cefepime Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cefepime Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cefepime Sales by Type (2020-2031)
4.1.1 Global Cefepime Sales by Type (2020-2025)
4.1.2 Global Cefepime Sales by Type (2026-2031)
4.1.3 Global Cefepime Sales Market Share by Type (2020-2031)
4.2 Global Cefepime Revenue by Type (2020-2031)
4.2.1 Global Cefepime Revenue by Type (2020-2025)
4.2.2 Global Cefepime Revenue by Type (2026-2031)
4.2.3 Global Cefepime Revenue Market Share by Type (2020-2031)
4.3 Global Cefepime Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cefepime Sales by Application (2020-2031)
5.1.1 Global Cefepime Sales by Application (2020-2025)
5.1.2 Global Cefepime Sales by Application (2026-2031)
5.1.3 Global Cefepime Sales Market Share by Application (2020-2031)
5.2 Global Cefepime Revenue by Application (2020-2031)
5.2.1 Global Cefepime Revenue by Application (2020-2025)
5.2.2 Global Cefepime Revenue by Application (2026-2031)
5.2.3 Global Cefepime Revenue Market Share by Application (2020-2031)
5.3 Global Cefepime Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Cefepime Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Apotex
6.2.1 Apotex Company Information
6.2.2 Apotex Description and Business Overview
6.2.3 Apotex Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Apotex Cefepime Product Portfolio
6.2.5 Apotex Recent Developments/Updates
6.3 B. Braun Medical
6.3.1 B. Braun Medical Company Information
6.3.2 B. Braun Medical Description and Business Overview
6.3.3 B. Braun Medical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.3.4 B. Braun Medical Cefepime Product Portfolio
6.3.5 B. Braun Medical Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Cefepime Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Perrigo
6.5.1 Perrigo Company Information
6.5.2 Perrigo Description and Business Overview
6.5.3 Perrigo Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Perrigo Cefepime Product Portfolio
6.5.5 Perrigo Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Company Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Fresenius Kabi Cefepime Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Sandoz (Novartis)
6.7.1 Sandoz (Novartis) Company Information
6.7.2 Sandoz (Novartis) Description and Business Overview
6.7.3 Sandoz (Novartis) Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sandoz (Novartis) Cefepime Product Portfolio
6.7.5 Sandoz (Novartis) Recent Developments/Updates
6.8 Piramal Critical Care
6.8.1 Piramal Critical Care Company Information
6.8.2 Piramal Critical Care Description and Business Overview
6.8.3 Piramal Critical Care Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Piramal Critical Care Cefepime Product Portfolio
6.8.5 Piramal Critical Care Recent Developments/Updates
6.9 Meitheal Pharmaceuticals
6.9.1 Meitheal Pharmaceuticals Company Information
6.9.2 Meitheal Pharmaceuticals Description and Business Overview
6.9.3 Meitheal Pharmaceuticals Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Meitheal Pharmaceuticals Cefepime Product Portfolio
6.9.5 Meitheal Pharmaceuticals Recent Developments/Updates
6.10 BMS
6.10.1 BMS Company Information
6.10.2 BMS Description and Business Overview
6.10.3 BMS Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.10.4 BMS Cefepime Product Portfolio
6.10.5 BMS Recent Developments/Updates
6.11 Qilu Pharmaceutical
6.11.1 Qilu Pharmaceutical Company Information
6.11.2 Qilu Pharmaceutical Description and Business Overview
6.11.3 Qilu Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Qilu Pharmaceutical Cefepime Product Portfolio
6.11.5 Qilu Pharmaceutical Recent Developments/Updates
6.12 Sinopharm
6.12.1 Sinopharm Company Information
6.12.2 Sinopharm Description and Business Overview
6.12.3 Sinopharm Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sinopharm Cefepime Product Portfolio
6.12.5 Sinopharm Recent Developments/Updates
6.13 Shanghai Xinfeng Pharmaceutical
6.13.1 Shanghai Xinfeng Pharmaceutical Company Information
6.13.2 Shanghai Xinfeng Pharmaceutical Description and Business Overview
6.13.3 Shanghai Xinfeng Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shanghai Xinfeng Pharmaceutical Cefepime Product Portfolio
6.13.5 Shanghai Xinfeng Pharmaceutical Recent Developments/Updates
6.14 Hebei Huamin Pharmaceutical
6.14.1 Hebei Huamin Pharmaceutical Company Information
6.14.2 Hebei Huamin Pharmaceutical Description and Business Overview
6.14.3 Hebei Huamin Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hebei Huamin Pharmaceutical Cefepime Product Portfolio
6.14.5 Hebei Huamin Pharmaceutical Recent Developments/Updates
6.15 Nanjing Haichen Pharmaceutical
6.15.1 Nanjing Haichen Pharmaceutical Company Information
6.15.2 Nanjing Haichen Pharmaceutical Description and Business Overview
6.15.3 Nanjing Haichen Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Nanjing Haichen Pharmaceutical Cefepime Product Portfolio
6.15.5 Nanjing Haichen Pharmaceutical Recent Developments/Updates
6.16 Shandong Luoxin Pharmaceutical Group
6.16.1 Shandong Luoxin Pharmaceutical Group Company Information
6.16.2 Shandong Luoxin Pharmaceutical Group Description and Business Overview
6.16.3 Shandong Luoxin Pharmaceutical Group Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Shandong Luoxin Pharmaceutical Group Cefepime Product Portfolio
6.16.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
6.17 Guangzhou Baiyunshan Tianxin Pharmaceutical
6.17.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information
6.17.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview
6.17.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Product Portfolio
6.17.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates
6.18 Yuekang Pharmaceutical Group
6.18.1 Yuekang Pharmaceutical Group Company Information
6.18.2 Yuekang Pharmaceutical Group Description and Business Overview
6.18.3 Yuekang Pharmaceutical Group Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Yuekang Pharmaceutical Group Cefepime Product Portfolio
6.18.5 Yuekang Pharmaceutical Group Recent Developments/Updates
6.19 Chengdu Beite Pharmaceutical
6.19.1 Chengdu Beite Pharmaceutical Company Information
6.19.2 Chengdu Beite Pharmaceutical Description and Business Overview
6.19.3 Chengdu Beite Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Chengdu Beite Pharmaceutical Cefepime Product Portfolio
6.19.5 Chengdu Beite Pharmaceutical Recent Developments/Updates
6.20 Jiangsu Hengrui Pharmaceutical
6.20.1 Jiangsu Hengrui Pharmaceutical Company Information
6.20.2 Jiangsu Hengrui Pharmaceutical Description and Business Overview
6.20.3 Jiangsu Hengrui Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Jiangsu Hengrui Pharmaceutical Cefepime Product Portfolio
6.20.5 Jiangsu Hengrui Pharmaceutical Recent Developments/Updates
6.21 Hainan Star Pharmaceutical
6.21.1 Hainan Star Pharmaceutical Company Information
6.21.2 Hainan Star Pharmaceutical Description and Business Overview
6.21.3 Hainan Star Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Hainan Star Pharmaceutical Cefepime Product Portfolio
6.21.5 Hainan Star Pharmaceutical Recent Developments/Updates
6.22 Hainan Hailing Pharmaceutical
6.22.1 Hainan Hailing Pharmaceutical Company Information
6.22.2 Hainan Hailing Pharmaceutical Description and Business Overview
6.22.3 Hainan Hailing Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Hainan Hailing Pharmaceutical Cefepime Product Portfolio
6.22.5 Hainan Hailing Pharmaceutical Recent Developments/Updates
6.23 Shenzhen Xinlitai Pharmaceutical
6.23.1 Shenzhen Xinlitai Pharmaceutical Company Information
6.23.2 Shenzhen Xinlitai Pharmaceutical Description and Business Overview
6.23.3 Shenzhen Xinlitai Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Shenzhen Xinlitai Pharmaceutical Cefepime Product Portfolio
6.23.5 Shenzhen Xinlitai Pharmaceutical Recent Developments/Updates
6.24 Shenzhen Lijian Pharmaceutical
6.24.1 Shenzhen Lijian Pharmaceutical Company Information
6.24.2 Shenzhen Lijian Pharmaceutical Description and Business Overview
6.24.3 Shenzhen Lijian Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Shenzhen Lijian Pharmaceutical Cefepime Product Portfolio
6.24.5 Shenzhen Lijian Pharmaceutical Recent Developments/Updates
6.25 Suzhou Dongrui Pharmaceutical
6.25.1 Suzhou Dongrui Pharmaceutical Company Information
6.25.2 Suzhou Dongrui Pharmaceutical Description and Business Overview
6.25.3 Suzhou Dongrui Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Suzhou Dongrui Pharmaceutical Cefepime Product Portfolio
6.25.5 Suzhou Dongrui Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cefepime Industry Chain Analysis
7.2 Cefepime Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cefepime Production Mode & Process Analysis
7.4 Cefepime Sales and Marketing
7.4.1 Cefepime Sales Channels
7.4.2 Cefepime Distributors
7.5 Cefepime Customer Analysis
8 Cefepime Market Dynamics
8.1 Cefepime Industry Trends
8.2 Cefepime Market Drivers
8.3 Cefepime Market Challenges
8.4 Cefepime Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Cefepime Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cefepime Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cefepime Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cefepime Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Cefepime Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cefepime Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cefepime Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cefepime Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cefepime, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cefepime, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cefepime, Product Type & Application
 Table 12. Global Key Manufacturers of Cefepime, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cefepime by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cefepime as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cefepime Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cefepime Sales by Region (2020-2025) & (K Units)
 Table 18. Global Cefepime Sales Market Share by Region (2020-2025)
 Table 19. Global Cefepime Sales by Region (2026-2031) & (K Units)
 Table 20. Global Cefepime Sales Market Share by Region (2026-2031)
 Table 21. Global Cefepime Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cefepime Revenue Market Share by Region (2020-2025)
 Table 23. Global Cefepime Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cefepime Revenue Market Share by Region (2026-2031)
 Table 25. North America Cefepime Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cefepime Sales by Country (2020-2025) & (K Units)
 Table 27. North America Cefepime Sales by Country (2026-2031) & (K Units)
 Table 28. North America Cefepime Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cefepime Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cefepime Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cefepime Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Cefepime Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Cefepime Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cefepime Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cefepime Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cefepime Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Cefepime Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Cefepime Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cefepime Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cefepime Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cefepime Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Cefepime Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Cefepime Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cefepime Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cefepime Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cefepime Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Cefepime Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Cefepime Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cefepime Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cefepime Sales (K Units) by Type (2020-2025)
 Table 51. Global Cefepime Sales (K Units) by Type (2026-2031)
 Table 52. Global Cefepime Sales Market Share by Type (2020-2025)
 Table 53. Global Cefepime Sales Market Share by Type (2026-2031)
 Table 54. Global Cefepime Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cefepime Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cefepime Revenue Market Share by Type (2020-2025)
 Table 57. Global Cefepime Revenue Market Share by Type (2026-2031)
 Table 58. Global Cefepime Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Cefepime Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Cefepime Sales (K Units) by Application (2020-2025)
 Table 61. Global Cefepime Sales (K Units) by Application (2026-2031)
 Table 62. Global Cefepime Sales Market Share by Application (2020-2025)
 Table 63. Global Cefepime Sales Market Share by Application (2026-2031)
 Table 64. Global Cefepime Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cefepime Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cefepime Revenue Market Share by Application (2020-2025)
 Table 67. Global Cefepime Revenue Market Share by Application (2026-2031)
 Table 68. Global Cefepime Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Cefepime Price (US$/Unit) by Application (2026-2031)
 Table 70. Baxter Company Information
 Table 71. Baxter Description and Business Overview
 Table 72. Baxter Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Baxter Cefepime Product
 Table 74. Baxter Recent Developments/Updates
 Table 75. Apotex Company Information
 Table 76. Apotex Description and Business Overview
 Table 77. Apotex Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Apotex Cefepime Product
 Table 79. Apotex Recent Developments/Updates
 Table 80. B. Braun Medical Company Information
 Table 81. B. Braun Medical Description and Business Overview
 Table 82. B. Braun Medical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. B. Braun Medical Cefepime Product
 Table 84. B. Braun Medical Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Pfizer Cefepime Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Perrigo Company Information
 Table 91. Perrigo Description and Business Overview
 Table 92. Perrigo Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Perrigo Cefepime Product
 Table 94. Perrigo Recent Developments/Updates
 Table 95. Fresenius Kabi Company Information
 Table 96. Fresenius Kabi Description and Business Overview
 Table 97. Fresenius Kabi Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Fresenius Kabi Cefepime Product
 Table 99. Fresenius Kabi Recent Developments/Updates
 Table 100. Sandoz (Novartis) Company Information
 Table 101. Sandoz (Novartis) Description and Business Overview
 Table 102. Sandoz (Novartis) Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Sandoz (Novartis) Cefepime Product
 Table 104. Sandoz (Novartis) Recent Developments/Updates
 Table 105. Piramal Critical Care Company Information
 Table 106. Piramal Critical Care Description and Business Overview
 Table 107. Piramal Critical Care Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Piramal Critical Care Cefepime Product
 Table 109. Piramal Critical Care Recent Developments/Updates
 Table 110. Meitheal Pharmaceuticals Company Information
 Table 111. Meitheal Pharmaceuticals Description and Business Overview
 Table 112. Meitheal Pharmaceuticals Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Meitheal Pharmaceuticals Cefepime Product
 Table 114. Meitheal Pharmaceuticals Recent Developments/Updates
 Table 115. BMS Company Information
 Table 116. BMS Description and Business Overview
 Table 117. BMS Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. BMS Cefepime Product
 Table 119. BMS Recent Developments/Updates
 Table 120. Qilu Pharmaceutical Company Information
 Table 121. Qilu Pharmaceutical Description and Business Overview
 Table 122. Qilu Pharmaceutical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Qilu Pharmaceutical Cefepime Product
 Table 124. Qilu Pharmaceutical Recent Developments/Updates
 Table 125. Sinopharm Company Information
 Table 126. Sinopharm Description and Business Overview
 Table 127. Sinopharm Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sinopharm Cefepime Product
 Table 129. Sinopharm Recent Developments/Updates
 Table 130. Shanghai Xinfeng Pharmaceutical Company Information
 Table 131. Shanghai Xinfeng Pharmaceutical Description and Business Overview
 Table 132. Shanghai Xinfeng Pharmaceutical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Shanghai Xinfeng Pharmaceutical Cefepime Product
 Table 134. Shanghai Xinfeng Pharmaceutical Recent Developments/Updates
 Table 135. Hebei Huamin Pharmaceutical Company Information
 Table 136. Hebei Huamin Pharmaceutical Description and Business Overview
 Table 137. Hebei Huamin Pharmaceutical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Hebei Huamin Pharmaceutical Cefepime Product
 Table 139. Hebei Huamin Pharmaceutical Recent Developments/Updates
 Table 140. Nanjing Haichen Pharmaceutical Company Information
 Table 141. Nanjing Haichen Pharmaceutical Description and Business Overview
 Table 142. Nanjing Haichen Pharmaceutical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Nanjing Haichen Pharmaceutical Cefepime Product
 Table 144. Nanjing Haichen Pharmaceutical Recent Developments/Updates
 Table 145. Shandong Luoxin Pharmaceutical Group Company Information
 Table 146. Shandong Luoxin Pharmaceutical Group Description and Business Overview
 Table 147. Shandong Luoxin Pharmaceutical Group Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Shandong Luoxin Pharmaceutical Group Cefepime Product
 Table 149. Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
 Table 150. Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information
 Table 151. Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview
 Table 152. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Product
 Table 154. Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates
 Table 155. Yuekang Pharmaceutical Group Company Information
 Table 156. Yuekang Pharmaceutical Group Description and Business Overview
 Table 157. Yuekang Pharmaceutical Group Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Yuekang Pharmaceutical Group Cefepime Product
 Table 159. Yuekang Pharmaceutical Group Recent Developments/Updates
 Table 160. Chengdu Beite Pharmaceutical Company Information
 Table 161. Chengdu Beite Pharmaceutical Description and Business Overview
 Table 162. Chengdu Beite Pharmaceutical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Chengdu Beite Pharmaceutical Cefepime Product
 Table 164. Chengdu Beite Pharmaceutical Recent Developments/Updates
 Table 165. Jiangsu Hengrui Pharmaceutical Company Information
 Table 166. Jiangsu Hengrui Pharmaceutical Description and Business Overview
 Table 167. Jiangsu Hengrui Pharmaceutical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Jiangsu Hengrui Pharmaceutical Cefepime Product
 Table 169. Jiangsu Hengrui Pharmaceutical Recent Developments/Updates
 Table 170. Hainan Star Pharmaceutical Company Information
 Table 171. Hainan Star Pharmaceutical Description and Business Overview
 Table 172. Hainan Star Pharmaceutical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Hainan Star Pharmaceutical Cefepime Product
 Table 174. Hainan Star Pharmaceutical Recent Developments/Updates
 Table 175. Hainan Hailing Pharmaceutical Company Information
 Table 176. Hainan Hailing Pharmaceutical Description and Business Overview
 Table 177. Hainan Hailing Pharmaceutical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Hainan Hailing Pharmaceutical Cefepime Product
 Table 179. Hainan Hailing Pharmaceutical Recent Developments/Updates
 Table 180. Shenzhen Xinlitai Pharmaceutical Company Information
 Table 181. Shenzhen Xinlitai Pharmaceutical Description and Business Overview
 Table 182. Shenzhen Xinlitai Pharmaceutical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Shenzhen Xinlitai Pharmaceutical Cefepime Product
 Table 184. Shenzhen Xinlitai Pharmaceutical Recent Developments/Updates
 Table 185. Shenzhen Lijian Pharmaceutical Company Information
 Table 186. Shenzhen Lijian Pharmaceutical Description and Business Overview
 Table 187. Shenzhen Lijian Pharmaceutical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Shenzhen Lijian Pharmaceutical Cefepime Product
 Table 189. Shenzhen Lijian Pharmaceutical Recent Developments/Updates
 Table 190. Suzhou Dongrui Pharmaceutical Company Information
 Table 191. Suzhou Dongrui Pharmaceutical Description and Business Overview
 Table 192. Suzhou Dongrui Pharmaceutical Cefepime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 193. Suzhou Dongrui Pharmaceutical Cefepime Product
 Table 194. Suzhou Dongrui Pharmaceutical Recent Developments/Updates
 Table 195. Key Raw Materials Lists
 Table 196. Raw Materials Key Suppliers Lists
 Table 197. Cefepime Distributors List
 Table 198. Cefepime Customers List
 Table 199. Cefepime Market Trends
 Table 200. Cefepime Market Drivers
 Table 201. Cefepime Market Challenges
 Table 202. Cefepime Market Restraints
 Table 203. Research Programs/Design for This Report
 Table 204. Key Data Information from Secondary Sources
 Table 205. Key Data Information from Primary Sources
 Table 206. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cefepime
 Figure 2. Global Cefepime Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cefepime Market Share by Type: 2024 & 2031
 Figure 4. Intramuscular Injection Product Picture
 Figure 5. Intravenous Drug Delivery Product Picture
 Figure 6. Global Cefepime Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cefepime Market Share by Application: 2024 & 2031
 Figure 8. Lower Respiratory Tract Infection
 Figure 9. Urinary Tract Infection
 Figure 10. Skin And Soft Tissue Infections
 Figure 11. Abdominal Cavity Infection
 Figure 12. Gynecologic Infection
 Figure 13. Sepsis
 Figure 14. Neutrophilic Fever
 Figure 15. Global Cefepime Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Cefepime Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Cefepime Sales (2020-2031) & (K Units)
 Figure 18. Global Cefepime Average Price (US$/Unit) & (2020-2031)
 Figure 19. Cefepime Report Years Considered
 Figure 20. Cefepime Sales Share by Manufacturers in 2024
 Figure 21. Global Cefepime Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Cefepime Players: Market Share by Revenue in Cefepime in 2024
 Figure 23. Cefepime Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Cefepime Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Cefepime Sales Market Share by Country (2020-2031)
 Figure 26. North America Cefepime Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Cefepime Sales Market Share by Country (2020-2031)
 Figure 30. Europe Cefepime Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Cefepime Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Cefepime Revenue Market Share by Region (2020-2031)
 Figure 38. China Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Cefepime Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Cefepime Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Cefepime Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Cefepime Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Cefepime Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Cefepime by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Cefepime by Type (2020-2031)
 Figure 60. Global Cefepime Price (US$/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Cefepime by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Cefepime by Application (2020-2031)
 Figure 63. Global Cefepime Price (US$/Unit) by Application (2020-2031)
 Figure 64. Cefepime Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart